Recursion Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Dec '25 Dec 3, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	44,669	55,558	36,109	28,508	59,346	-	Upgrade
Market Cap Growth	25.80%	53.86%	26.67%	-51.96%	-	-	Upgrade
Enterprise Value	34,163	48,535	30,432	20,657	47,493	-	Upgrade
PS Ratio	55.74	45.32	47.92	36.68	284.42	-	Upgrade
PB Ratio	2.33	2.58	4.61	3.01	5.33	-	Upgrade
P/TBV Ratio	4.33	4.85	5.70	3.02	5.35	-	Upgrade
EV/Sales Ratio	42.98	39.59	40.38	26.58	227.62	-	Upgrade
Debt / Equity Ratio	0.08	0.11	0.11	0.11	0.00	0.05	Upgrade
Asset Turnover	0.04	0.06	0.07	0.06	0.02	0.02	Upgrade
Quick Ratio	4.39	3.43	4.24	5.51	11.27	11.36	Upgrade
Current Ratio	4.60	3.81	4.70	5.68	11.46	11.54	Upgrade
Return on Equity (ROE)	-91.06%	-61.90%	-69.12%	-46.56%	-47.51%	-54.57%	Upgrade
Return on Assets (ROA)	-42.20%	-28.48%	-32.29%	-23.42%	-25.14%	-26.44%	Upgrade
Return on Capital (ROIC)	-51.43%	-36.13%	-41.64%	-28.43%	-28.62%	-30.76%	Upgrade
Return on Capital Employed (ROCE)	-57.70%	-38.00%	-62.50%	-40.90%	-32.40%	-30.70%	Upgrade
Earnings Yield	-29.38%	-17.39%	-15.36%	-16.39%	-6.44%	-	Upgrade
FCF Yield	-18.38%	-13.98%	-14.03%	-8.25%	-6.85%	-	Upgrade
Buyback Yield / Dilution	-63.30%	-31.92%	-18.41%	-40.04%	-475.48%	-0.98%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.